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STUDIES ON THE ECZEMATOUS SENSITIZATION
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RELATION TO 2:4 DINITROCHLOROBENZENE*
A. ROSTENBERG, JR., M.D.
In the study of sensitizations to simple chemicals, there are two somewhat
related chemical problems. One is the nature of the union between the sensitizing
chemical and the tissues of the host in order to engender the eczematous sensi-
tization, and the other is in what chemical respects can a substance that is
capable of evoking a reaction in the already sensitized animal deviate from the
parent sensitizing compound? It has been reasonably well shown, originally by
Landsteiner (1) and subsequently confirmed by others, that simple chemical
compounds which are capable of inducing the eczematous variety of the delayed
type of allergic sensitization enter into some sort of union with the tissues of
the host. The simplest hypothesis is that a protein conjugate is made. There
seems to be direct chemical evidence for this type of union with certain classes
of compounds, such as substituted nitro- and halo-benzenes, especially the di-
nitrophenyls. Such a union may not be true for all substances which yield an
eczematous sensitization, e.g., nickel, for, as GeIl (2) states:
"Many chemical compounds which act as sensitizers have one general fea-
ture in common: they are capable of reacting with a group or groups in the mole-
cule of a protein to form a conjugate. A second type of sensitizer is not able
itself to combine with protein, but may be metabolized in the body to a deriva-
tive possessing such powers of combination. There may be a third category of
sensitizers which do not react chemically but form strong adsorption complexes
with protein. In any case the conjugate or adsorption complex so formed will
become aritigenically distinct from the parent protein, and if the sensitizer
gains access to the tissues of an animal the proteins of the latter may be ren-
dered antigenic."
Much less work has been done to determine how far and in what respect one
can deviate chemically from the compound to which the host was originally
sensitized and still obtain a reaction. Rostenberg and Kanof (3) studied this
problem in persons who had been sensitized to 2:4 dinitrochlorobenzene and
came to the conclusion that "in the case of the substituted halo-benzenes, for
the body to react to a compound other than the one to which it is sensitized, it
appears that two factors must be present: 1) a geometric resemblance of the
original to the new compound; and 2) the new compound must be capable of
forming conjugates of a kind similar to the original."
Subsequently Eisen and colleagues (4) in several studies have furnished rather
detailed knowledge concerning the nature of the union and the chemical dif-
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ferences between elicitors (that is, compounds capable of producing a reaction
in the eczematously sensitized individual) and non-elicitors (that is, compounds
not capable of producing the eczematous reaction). Eisen et al state: "It is
concluded that a necessary condition for the elicitation of delayed allergic skin
reactions by haptens is the combination of the latter with skin protein through
the formation of bonds of the covalent type. No choice is yet possible amongst
the several possible explanations which are advanced to account for the obliga-
tory character of protein combination." While possibly not chemically elegant
terminology, it might be well to think of compounds such as 2:4 dinitrochioro-
benzene (2:4 D) as consisting of two parts: 1) the "active" or conjugating por-
tion of the molecule, which is the means by which it attaches to the protein.
This may be termed the molecular hook or linker, and 2) the "passive" portion
of the molecule, which may be thought of as the configurational residue. In
other words, for compound B to yield a reaction in an animal eczematously
sensitive to compound A, two factors must be present: 1) compound B must
have a group (a hook) by which it can attach to protein, possibly a particular
kind of union is required, 2) having attached, the configuration of the residue
insinuated onto the surface of the protein molecule must he geometrically (?)
close to the configuration introduced by A. In the case of sensitization with 2:4 D,
the chlorine atom is the hook by which the compound attaches to the protein,
and the metadinitrophenyl residue is the configurational structure introduced
onto the protein. As examples of the need for both an appropriate "hook" and
a proper configurational residue, the results of testing individuals sensitized to
2:4 D with various structurally similar compounds will be cited. Animals or
persons sensitized to 2:4 D react just about as well 2:4 dinitrobromobenzene or
2:4 dinitroiodobenzene because in both of these compounds an adequate hook
exists, namely, the halogen atom and the configuration introduced onto the
protein is the same as that introduced by 2:4 D. A compound such as 2:4 di-
nitroaminobenzene has the appropriate configuration but lacks the ability to
attach, for Rostenberg and Kanof, as well as Eisen and colleagues, found that
individuals sensitive to 2:4 D failed to react to this compound. On the other hand,
3:4 dichloronitrobenzene probably attaches adequately to the protein but the
configuration introduced is apparently not sufficiently akin to the metadinitro-
phenyl structure to elicit reactions in an individual sensitive to 2:4 D (Rosten-
berg and Kanof).
Several investigators (Landsteiner, IHaxthausen (5), Rostenberg) have shown
that both guinea pigs and persons sensitive to 2:4 D fail to react to m-dinitro-
benzene (mD), either by application or by intradermal injection. NOW, as mD
has the configuration of the groups introduced by 2:4 D, the failure of the sensi-
tized animal to react implies that mD is incapable of entering into the requisite
union with body protein to form the complete antigen, or at least is not able to
form these conjugates sufficiently rapidly to yield an adequate local concentra-
tion. This last point is considered in more detail later.
In the course of some studies on the general problem of "desensitizing" the
animal made eczematously sensitive to a simple chemical it was thought that
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mD might inhibit reactions to 2:4 D in animals sensitized to this compound.
Landsteiner (6) showed that certain simple chemical haptens inhibit precipita-
tion reactions to the complete antigen. As is well known, he demonstrated that
if a precipitating serum was first exposed to suitable concentrations of the simple
chemical hapten and then the conjugated antigen (a protein united with the
simple chemical hapten) introduced precipitation failed to occur; the theory
being that the hapten was capable of uniting sufficiently with the antibody so
as to utilize its combining sites, so that when antibody so treated was exposed to
the complete antigen (the conjugated protein) there was no means by which a
union between the two could occur; but the hapten-antibody combination did
not produce molecular aggregates sufficiently large to cause precipitation. In a
somewhat analogous fashion it was thought that mD might inhibit reactions to
2:4 D.
EXPERIMENTAL
Guinea pigs which had been sensitized to 2:4 D were exposed to mD in three
different ways: 1) by the intraperitoneal injections of a solution of mD, 2) by
implanting crystals of mD under the skin of the guinea pigs, and 3) by injecting
intradermally solutions of ml). In all cases the animals were subsequently tested
by the cutaneous application of 2:4 D. In no case was there any effect upon the
reactivity to 2:4 D. In other words, the animals treated with the mD reacted
just as well as animals not so treated. In the case where the mD was injected in-
tradermally the 2:4 D was subsequently applied to the very site into which the
mD had been introduced, but as already stated, this did not appear to inhibit
the reaction to the 2:4 D. It was also thought that mD might have an influence
on the duration of a sensitivity to 2:4 D. Such did not appear to be the case.
Animals eczematously sensitized to 2:4 D did not have the duration of their
sensitivity altered by injections of mD, as compared to control animals treated
with acetone.
In the course of these various experiments a group of guinea pigs not previously
exposed to 2:4 D had been treated by placing mD crystals subcutaneously. This
\\ras done by cutting through the full thickness of the skin and with an instru-
ment, such as a hemostat, bluntly separating the skin for a very short distance
from the underlying fascia. A pinch of mD crystals was then placed in the pouch
and the incision closed with one or two sutures. These animals when subsequently
cutaneously tested with 2:4 D proved to be sensitive to the application of this
material in dilutions of 1: 1000 in acetone—in a few cases in higher dilution.
This experiment has been repeated with the same results.*f
DISCUSSION
It thus appears that mD, a compound incapable of eliciting a reaction in per-
sons or animals eczematously sensitive to 2:4 D, nevertheless can sensitize
* Very recently we have tried the effect of injecting intracutaneously 10 per cent ace-
tone solutions of mD. So far we have failed to develop a sensitivity to 2:4 by this method.
t Distillation Products Industries, from whom we purchased the mD, kindly ran a test
for chioro impurities and found none.
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guinea pigs to this same compound. At first sight this would appear somewhat
paradoxical, but it is believed that a reasonable explanation in line with ac-
cepted theories can be proffered.
As already stated, mD has the dinitrophenyl configuration of 2:4 B but fails
to cause a reaction in the animal already sensitized to 2:4 D because it (mD) is
incapable of conjugation. It would appear, however, that the phrase "incapable
of conjugation" must be regarded in a relative fashion. It would now appear that
mD is capable of conjugating with the same proteins that 2:4 B conjugates
with, but the rate at which the conjugated protein forms with mD is below the
rate at which the protein or the mD itself or both is carried away or degraded,
or both; so that when a 2:4 D sensitive animal is tested with mD the concen-
tration of conjugated protein existing at the test site at any one time is very small,
presumably below the level of clinical detectability. However, when crystals of
mD are introduced, over a period of time a sufficient number of appropriate
protein conjugates are formed which will ultimately engender the enzymic
adaptation in an adequate number of R.E. cells, so as to render the host generally
eczematously sensitive to the material in question. * This finding is actually
somewhat analogous to the situation that exists in anaphylactic sensitivities
where it is reasonably well established that a much smaller amount of antigen
is required to sensitize than to elicit the acute anaphylactic reaction in the al-
ready sensitized animal.
SUMMARY AND CONCLUSIONS
1. A review of the theory regarding the chemical characteristics of compounds
that are able to elicit a reaction in an animal eczematously sensitized to some
other compound has been given.
2. This theory has been explicitly discussed with respect to 2:4 dinitrochioro-
benzene and metadinitrobenzene. It has been pointed out that metadinitro-
benzene is incapable of causing a reaction in the eczematously sensitive animal,
presumably, because it cannot form appropriate conjugates in sufficient con-
centration within a requisite time.
3. It has, however, been shown that metadinitrobenzene can engender a sensi-
tivity to a metadinitrophenyl protein conjugate, so that when the animal is sub-
sequently tested with 2:4 dinitrochlorobenzene the animal will be found to be
sensitive.
4. Metadinitrobenzene was found to be incapable of inhibiting reactions to
2:4 dinitrochlorobenzene or to affect the duration of a sensitization to 2:4 dinitro-
chlorobenzene.
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